European Case Law Identifier: | ECLI:EP:BA:2009:T205208.20090203 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 03 February 2009 | ||||||||
Case number: | T 2052/08 | ||||||||
Application number: | 97923186.7 | ||||||||
IPC class: | C12Q 1/68 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Methods for identifying a mutation in a gene of interest | ||||||||
Applicant name: | Ingenium Pharmaceuticals GmbH | ||||||||
Opponent name: | - | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Transitional provisions of the EPC 2000 Reimbursement of appeal fee pursuant to Rule 103(1)(b) EPC (yes) |
||||||||
Catchwords: |
see points 2 to 6 of the reasons |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t082052eu1.html
Date retrieved: 17 May 2021